#advanced fibrosis

The United States isn’t alone in grappling with this growing health problem.

Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.

Study finds people who took daily aspirin had a lower risk of NASH and advanced liver scarring.

The tool can predict whether people with fatty liver disease will develop advanced fibrosis with up to 92 percent accuracy.

However, in a small subset of those with advanced fibrosis or cirrhosis, liver damage remains the same or worsens post-cure.

A recent study compared rates of progression to decompensated cirrhosis among those who recently received hepatitis C treatment.

Individuals with advanced fibrosis or cirrhosis who are cured of hepatitis C virus (HCV) often see their liver damage reduced.

Those coinfected with hepatitis C and HIV who have advanced fibrosis should receive hep C therapy, because of the risk of developing liver dec...

The new therapy simeprevir is generally safe and well-tolerated among hep C patients with advanced liver fibrosis and improves treatment outco...